Evidence map›Paper›PMID 22728919›Full record

ArticleBiochemical pharmacology2012

Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: role of the proximal promoter GC-rich region.

Neal A Englert, Robert J Turesky, Weiguo Han, Erin E Bessette, Simon D Spivack, Michele Caggana, David C Spink, Barbara C Spink

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Epigenetic Regulations of AhR in the Aspect of Immunomodulation.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Neal A EnglertWadsworth Center, New York State Department of Health, Albany, NY 12201, USA.
Robert J Turesky
Weiguo Han
Erin E Bessette
Simon D Spivack
Michele Caggana
David C Spink
Barbara C Spink
Wadsworth Center · USAlbert Einstein College of Medicine · USNew York State Department of Health · USUniversity at Albany, State University of New York · US

Funding

Chemical markers of heterocyclic aromatic amines for human biomonitoringR01CA122320 · NCI · WADSWORTH CENTER · PI TURESKY, ROBERT J. · 2007 to 2018
$4.8M
Carcinogenicity of EstrogensR01CA081243 · NCI · WADSWORTH CENTER · PI SPINK, DAVID C · 2000 to 2009
$1.9M
Quantitative Gene Expression in Human Lung EpitheliumR01CA106186 · NCI · WADSWORTH CENTER · PI SPIVACK, SIMON D · 2003 to 2007
$1.8M
Early Functional Genetic and Epigenetic Changes in Human Lung CarcinogenesisRC1CA145422 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SPIVACK, SIMON D · 2009 to 2010
$999k
Individual Promoter SNP and CpG Methylation SignaturesR21CA104812 · NCI · WADSWORTH CENTER · PI SPIVACK, SIMON D · 2005 to 2006
$302k
NCI NIH HHS R01 CA081243NCI NIH HHS R01 CA106186NCI NIH HHS R01 CA122320NCI NIH HHS R21 CA104812NCI NIH HHS RC1 CA145422
6 · The paper itself

Abstract

The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, contributes to carcinogenesis through its role in the regulation of cytochrome P450 1 (CYP1)-catalyzed metabolism of carcinogens. Here, we investigated genetic and epigenetic mechanisms that affect AhR expression. Analyses of the human AHR proximal promoter in MCF-7 human breast cancer cells using luciferase assays and electrophoretic mobility shift assays revealed multiple specificity protein (Sp) 1 binding sequences that are transcriptional activators in vitro. The regulation of AhR expression was evaluated in long-term estrogen exposed (LTEE) MCF-7 cells, which showed increased AhR expression, enhanced CYP1 inducibility, and increased capacity to form DNA adducts when exposed to the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. The increased AhR expression in LTEE cells was found not to result from increased mRNA stability, differential RNA processing, or decreased DNA methylation. Analysis of the AHR proximal promoter region using chromatin immunoprecipitation confirmed that enhanced expression of AhR in LTEE cells involves changes in histone modifications, notably decreased trimethylation of histone 3, lysine 27. Upon further examination of the GC-rich Sp1-binding region, we confirmed that it contains a polymorphic (GGGGC)(n) repeat. In a population of newborns from New York State, the allele frequency of (GGGGC)(n) was n = 4 > 5 ≫ 6, 2. Circular dichroism spectroscopy revealed the ability of sequences of this GC-rich region to form guanine-quadruplex structures in vitro. These studies revealed multiple levels at which AhR expression may be controlled, and offer additional insights into mechanisms regulating AhR expression that can ultimately impact carcinogenesis.

Indexed as

Epigenesis, GeneticGC Rich SequenceGene Expression Regulation, NeoplasticPromoter Regions, GeneticCell Line, TumorChromatin ImmunoprecipitationChromatography, LiquidCircular DichroismCytochrome P-450 CYP1A1Electrophoretic Mobility Shift AssayHumansMutagenesis, Site-DirectedReal-Time Polymerase Chain ReactionReceptors, Aryl HydrocarbonSpectrometry, Mass, Electrospray IonizationSp Transcription FactorsCytochrome P-450 CYP1A1Receptors, Aryl HydrocarbonSp Transcription Factors

Identifiers

PMID22728919
PMCPMC3965201
OpenAlexW2072201043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.